REFERENCES
- Programme Advisory, National Laboratory Certification Programme, Substance Abuse and Mental Health Services Administration. 05 May 1993.
- Lafolie P, Beck O., Blennow G., Boréus L., Borg S., Elwin C.-E., Karlsson L., Odelius G. and Hjemdahl P. Importance of Creatinine Analyses for Urine When Screening for Abused Drugs. Clin. Chem. 1991; 37: 1927–1931.
- Fraser A.D. Analysis of Creatinine in Urine Drug Testing Programmes. Presented at: 44th Annual Meeting, Canadian Society of Forensic Science, Wolfville, Nova Scotia, 1997.
- Fraser A.D. Urine Drug Testing for Social Service Agencies: A Canadian Experience. Clin. Lab. Med. 1998; 18: 705–711.
- Whelton A., Watson, A.J. and Rock R.C. Nitrogen Metabolites and Renal Function. In: Burtis C.A. and Ashwood E.R., Editors, Textbook of Clinical Chemistry, Philadelphia, PA: W.B. Saunders Company, 1994; 1513–1575.
- Beekman Synchron CX® Delta Systems, Creatinine Chemistry Method—CRE3. Beckman Instruments, Brea, CA, USA.
- Balsom P.D., Soderlund K., Ekblom B. Creatine in Humans with Special Reference to Creatine Supplementation. Sports Med. 1994; 18: 268–80.
- Ropero-Miller J.D., Doering P.L. and Goldberger B. Oral Creatine Supplementation and its' Effect on Urinary Creatinine, pH, and Specific Gravity Measurements. Presented at: The International Association of Forensic Toxicologists and Society of Forensic Toxicologists Joint International Congress, Albuquerque, New Mexico, 1998.